Corrigendum to “Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial” [Journal of Clinical Lipidology, Volume 17, Issue 3, May–June 2023, Pages 342–355]

Alan Jones,Marcello Arca,Richard Jones,Veronica J. Alexander,Erik S.G. Stroes,Ioanna Gouni-Berthold,Lynnetta Watts,Sotirios Tsimikas,Shuting Xia,Daniel Gaudet,Joseph L. Witztum,Handrean Soran

doi:10.1016/j.jacl.2023.09.010

Corrigendum to “Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial” [Journal of Clinical Lipidology, Volume 17, Issue 3, May–June 2023, Pages 342–355]

Alan Jones, Marcello Arca

Open Access

https://doi.org/10.1016/j.jacl.2023.09.010

Copy DOI

Journal: Journal of Clinical Lipidology

Publication Date: Oct 1, 2023

Affiliation: University Hospitals Birmingham NHS Foundation Trust, Academic Medical Center, University of Cologne, University of California, San Diego

#Open-label Extension Trial #Chylomicronemia Syndrome + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Corrigendum to “Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial” [Journal of Clinical Lipidology, Volume 17, Issue 3, May–June 2023, Pages 342–355]

Full Text